PTJ
OME

Paul Tudor Jones’s Omega Protein OME Stock Holding History

Paul Tudor Jones’s Portfolio OME Stock Details OME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-18,081
Closed -$301K – 1417
2017
Q3 		$301K Sell
18,081
-2,099
-10% -$34.1K 0.01% 828
2017
Q2 		$361K Sell
20,180
-38,249
-65% -$715K 0.01% 694
2017
Q1 		$1.17M Buy
58,429
+15,446
+36% +$360K 0.04% 323
2016
Q4 		$1.08M Buy
42,983
+14,912
+53% +$352K 0.03% 339
2016
Q3 		$656K Sell
28,071
-1,037
-4% -$24.4K 0.02% 594
2016
Q2 		$582K Buy
29,108
+11,591
+66% +$216K 0.01% 735
2016
Q1 		$297K Sell
17,517
-4,066
-19% -$83.3K 0.01% 1302
2015
Q4 		$479K Buy
+21,583
New +$449K 0.01% 916
2014
Q4 		– Sell
-17,530
Closed -$219K – 1678
2014
Q3 		$219K Buy
+17,530
New +$244K 0.01% 1155

Paul Tudor Jones's OME Position: Q4 2017 in Review

Paul Tudor Jones sold out of Omega Protein (OME) in Q4 2017, closing a stake of 18,081 shares — an estimated $301K sold.

Paul Tudor Jones first reported a position in OME in Q3 2014 and held it in 9 quarters. The position peaked at $1.17M in Q1 2017. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.

  • Paul Tudor Jones reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
  • Paul Tudor Jones sold 18,081 Omega Protein shares in Q4 2017, an estimated $301K.
  • Paul Tudor Jones first reported a position in Omega Protein in Q3 2014 and held it in 9 quarters.
  • Paul Tudor Jones's Omega Protein position peaked at $1.17M in Q1 2017.
  • 0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.

Based on Tudor Investment Corp's 13F filing for Q4 2017, filed 14 Feb 2018.